nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—stomach cancer—esophageal cancer	0.698	1	CtDrD
Mitomycin—ABCB1—esophageal cancer	0.238	1	CbGaD
Mitomycin—Bone marrow toxicity—Cisplatin—esophageal cancer	0.00932	0.146	CcSEcCtD
Mitomycin—Irreversible renal failure—Cisplatin—esophageal cancer	0.00712	0.111	CcSEcCtD
Mitomycin—Metastatic neoplasm—Cisplatin—esophageal cancer	0.0035	0.0547	CcSEcCtD
Mitomycin—Haemolytic uraemic syndrome—Cisplatin—esophageal cancer	0.00307	0.048	CcSEcCtD
Mitomycin—Pulmonary toxicity—Cisplatin—esophageal cancer	0.00296	0.0462	CcSEcCtD
Mitomycin—Extravasation—Carboplatin—esophageal cancer	0.00262	0.041	CcSEcCtD
Mitomycin—Renal failure chronic—Cisplatin—esophageal cancer	0.00249	0.0389	CcSEcCtD
Mitomycin—Dry cough—Methotrexate—esophageal cancer	0.00238	0.0372	CcSEcCtD
Mitomycin—Pulmonary toxicity—Methotrexate—esophageal cancer	0.00162	0.0253	CcSEcCtD
Mitomycin—Myelosuppression—Cisplatin—esophageal cancer	0.00143	0.0223	CcSEcCtD
Mitomycin—Nephropathy toxic—Cisplatin—esophageal cancer	0.00117	0.0182	CcSEcCtD
Mitomycin—Necrosis—Cisplatin—esophageal cancer	0.000855	0.0134	CcSEcCtD
Mitomycin—Lung infiltration—Methotrexate—esophageal cancer	0.000785	0.0123	CcSEcCtD
Mitomycin—Extravasation—Cisplatin—esophageal cancer	0.000769	0.012	CcSEcCtD
Mitomycin—Haematemesis—Capecitabine—esophageal cancer	0.000712	0.0111	CcSEcCtD
Mitomycin—Ulcer—Cisplatin—esophageal cancer	0.000709	0.0111	CcSEcCtD
Mitomycin—Pain—Carboplatin—esophageal cancer	0.000698	0.0109	CcSEcCtD
Mitomycin—Body temperature increased—Carboplatin—esophageal cancer	0.000645	0.0101	CcSEcCtD
Mitomycin—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000537	0.00839	CcSEcCtD
Mitomycin—Haematemesis—Methotrexate—esophageal cancer	0.00053	0.00828	CcSEcCtD
Mitomycin—Burning sensation—Methotrexate—esophageal cancer	0.00053	0.00828	CcSEcCtD
Mitomycin—Ulcer—Capecitabine—esophageal cancer	0.000523	0.00817	CcSEcCtD
Mitomycin—Injection site reaction—Capecitabine—esophageal cancer	0.000492	0.00768	CcSEcCtD
Mitomycin—Necrosis—Methotrexate—esophageal cancer	0.000469	0.00733	CcSEcCtD
Mitomycin—Extravasation—Methotrexate—esophageal cancer	0.000422	0.00659	CcSEcCtD
Mitomycin—Thrombophlebitis—Capecitabine—esophageal cancer	0.000415	0.00648	CcSEcCtD
Mitomycin—Pancytopenia—Cisplatin—esophageal cancer	0.0004	0.00624	CcSEcCtD
Mitomycin—Ulcer—Methotrexate—esophageal cancer	0.000389	0.00608	CcSEcCtD
Mitomycin—Renal impairment—Capecitabine—esophageal cancer	0.000377	0.00589	CcSEcCtD
Mitomycin—Renal failure—Cisplatin—esophageal cancer	0.000369	0.00576	CcSEcCtD
Mitomycin—Stomatitis—Cisplatin—esophageal cancer	0.000366	0.00571	CcSEcCtD
Mitomycin—Pulmonary oedema—Methotrexate—esophageal cancer	0.000328	0.00512	CcSEcCtD
Mitomycin—Thrombophlebitis—Methotrexate—esophageal cancer	0.000309	0.00482	CcSEcCtD
Mitomycin—Alopecia—Cisplatin—esophageal cancer	0.000298	0.00465	CcSEcCtD
Mitomycin—Pancytopenia—Capecitabine—esophageal cancer	0.000295	0.0046	CcSEcCtD
Mitomycin—Erythema—Cisplatin—esophageal cancer	0.000293	0.00458	CcSEcCtD
Mitomycin—Vision blurred—Cisplatin—esophageal cancer	0.000276	0.00432	CcSEcCtD
Mitomycin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000272	0.00425	CcSEcCtD
Mitomycin—Renal failure—Capecitabine—esophageal cancer	0.000272	0.00425	CcSEcCtD
Mitomycin—Anaemia—Cisplatin—esophageal cancer	0.000271	0.00423	CcSEcCtD
Mitomycin—Stomatitis—Capecitabine—esophageal cancer	0.00027	0.00421	CcSEcCtD
Mitomycin—Malaise—Cisplatin—esophageal cancer	0.000265	0.00413	CcSEcCtD
Mitomycin—Leukopenia—Cisplatin—esophageal cancer	0.000263	0.0041	CcSEcCtD
Mitomycin—Discomfort—Cisplatin—esophageal cancer	0.000247	0.00385	CcSEcCtD
Mitomycin—Oedema—Cisplatin—esophageal cancer	0.000239	0.00374	CcSEcCtD
Mitomycin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000234	0.00366	CcSEcCtD
Mitomycin—Anorexia—Cisplatin—esophageal cancer	0.000228	0.00356	CcSEcCtD
Mitomycin—Alopecia—Capecitabine—esophageal cancer	0.000219	0.00343	CcSEcCtD
Mitomycin—Pancytopenia—Methotrexate—esophageal cancer	0.000219	0.00343	CcSEcCtD
Mitomycin—Erythema—Capecitabine—esophageal cancer	0.000216	0.00338	CcSEcCtD
Mitomycin—Dyspnoea—Cisplatin—esophageal cancer	0.000213	0.00333	CcSEcCtD
Mitomycin—Decreased appetite—Cisplatin—esophageal cancer	0.000208	0.00325	CcSEcCtD
Mitomycin—Drowsiness—Methotrexate—esophageal cancer	0.000206	0.00322	CcSEcCtD
Mitomycin—Pain—Cisplatin—esophageal cancer	0.000205	0.0032	CcSEcCtD
Mitomycin—Vision blurred—Capecitabine—esophageal cancer	0.000204	0.00318	CcSEcCtD
Mitomycin—Renal failure—Methotrexate—esophageal cancer	0.000202	0.00316	CcSEcCtD
Mitomycin—Stomatitis—Methotrexate—esophageal cancer	0.000201	0.00314	CcSEcCtD
Mitomycin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000201	0.00313	CcSEcCtD
Mitomycin—Anaemia—Capecitabine—esophageal cancer	0.0002	0.00312	CcSEcCtD
Mitomycin—Feeling abnormal—Cisplatin—esophageal cancer	0.000197	0.00308	CcSEcCtD
Mitomycin—Malaise—Capecitabine—esophageal cancer	0.000195	0.00305	CcSEcCtD
Mitomycin—Syncope—Capecitabine—esophageal cancer	0.000194	0.00303	CcSEcCtD
Mitomycin—Leukopenia—Capecitabine—esophageal cancer	0.000194	0.00302	CcSEcCtD
Mitomycin—Loss of consciousness—Capecitabine—esophageal cancer	0.00019	0.00297	CcSEcCtD
Mitomycin—Body temperature increased—Cisplatin—esophageal cancer	0.000189	0.00296	CcSEcCtD
Mitomycin—Cough—Capecitabine—esophageal cancer	0.000189	0.00295	CcSEcCtD
Mitomycin—Hypertension—Capecitabine—esophageal cancer	0.000187	0.00292	CcSEcCtD
Mitomycin—Discomfort—Capecitabine—esophageal cancer	0.000182	0.00284	CcSEcCtD
Mitomycin—Confusional state—Capecitabine—esophageal cancer	0.000178	0.00278	CcSEcCtD
Mitomycin—Oedema—Capecitabine—esophageal cancer	0.000176	0.00276	CcSEcCtD
Mitomycin—Shock—Capecitabine—esophageal cancer	0.000174	0.00271	CcSEcCtD
Mitomycin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000173	0.0027	CcSEcCtD
Mitomycin—Asthenia—Cisplatin—esophageal cancer	0.000172	0.00268	CcSEcCtD
Mitomycin—Anorexia—Capecitabine—esophageal cancer	0.000168	0.00263	CcSEcCtD
Mitomycin—Diarrhoea—Cisplatin—esophageal cancer	0.000164	0.00256	CcSEcCtD
Mitomycin—Alopecia—Methotrexate—esophageal cancer	0.000163	0.00255	CcSEcCtD
Mitomycin—Erythema—Methotrexate—esophageal cancer	0.000161	0.00251	CcSEcCtD
Mitomycin—Dyspnoea—Capecitabine—esophageal cancer	0.000157	0.00246	CcSEcCtD
Mitomycin—Decreased appetite—Capecitabine—esophageal cancer	0.000153	0.0024	CcSEcCtD
Mitomycin—Vomiting—Cisplatin—esophageal cancer	0.000152	0.00238	CcSEcCtD
Mitomycin—Fatigue—Capecitabine—esophageal cancer	0.000152	0.00238	CcSEcCtD
Mitomycin—Vision blurred—Methotrexate—esophageal cancer	0.000152	0.00237	CcSEcCtD
Mitomycin—Rash—Cisplatin—esophageal cancer	0.000151	0.00236	CcSEcCtD
Mitomycin—Pain—Capecitabine—esophageal cancer	0.000151	0.00236	CcSEcCtD
Mitomycin—Dermatitis—Cisplatin—esophageal cancer	0.000151	0.00236	CcSEcCtD
Mitomycin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000149	0.00233	CcSEcCtD
Mitomycin—Anaemia—Methotrexate—esophageal cancer	0.000149	0.00232	CcSEcCtD
Mitomycin—Feeling abnormal—Capecitabine—esophageal cancer	0.000145	0.00227	CcSEcCtD
Mitomycin—Malaise—Methotrexate—esophageal cancer	0.000145	0.00227	CcSEcCtD
Mitomycin—Leukopenia—Methotrexate—esophageal cancer	0.000144	0.00225	CcSEcCtD
Mitomycin—Nausea—Cisplatin—esophageal cancer	0.000142	0.00222	CcSEcCtD
Mitomycin—Cough—Methotrexate—esophageal cancer	0.00014	0.00219	CcSEcCtD
Mitomycin—Body temperature increased—Capecitabine—esophageal cancer	0.00014	0.00218	CcSEcCtD
Mitomycin—Discomfort—Methotrexate—esophageal cancer	0.000135	0.00211	CcSEcCtD
Mitomycin—Confusional state—Methotrexate—esophageal cancer	0.000132	0.00207	CcSEcCtD
Mitomycin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000129	0.00201	CcSEcCtD
Mitomycin—Asthenia—Capecitabine—esophageal cancer	0.000127	0.00198	CcSEcCtD
Mitomycin—Anorexia—Methotrexate—esophageal cancer	0.000125	0.00196	CcSEcCtD
Mitomycin—Diarrhoea—Capecitabine—esophageal cancer	0.000121	0.00189	CcSEcCtD
Mitomycin—Dyspnoea—Methotrexate—esophageal cancer	0.000117	0.00183	CcSEcCtD
Mitomycin—Somnolence—Methotrexate—esophageal cancer	0.000117	0.00182	CcSEcCtD
Mitomycin—Dizziness—Capecitabine—esophageal cancer	0.000117	0.00182	CcSEcCtD
Mitomycin—Decreased appetite—Methotrexate—esophageal cancer	0.000114	0.00178	CcSEcCtD
Mitomycin—Fatigue—Methotrexate—esophageal cancer	0.000113	0.00177	CcSEcCtD
Mitomycin—Pain—Methotrexate—esophageal cancer	0.000112	0.00175	CcSEcCtD
Mitomycin—Vomiting—Capecitabine—esophageal cancer	0.000112	0.00175	CcSEcCtD
Mitomycin—Rash—Capecitabine—esophageal cancer	0.000111	0.00174	CcSEcCtD
Mitomycin—Dermatitis—Capecitabine—esophageal cancer	0.000111	0.00174	CcSEcCtD
Mitomycin—Headache—Capecitabine—esophageal cancer	0.000111	0.00173	CcSEcCtD
Mitomycin—Feeling abnormal—Methotrexate—esophageal cancer	0.000108	0.00169	CcSEcCtD
Mitomycin—Nausea—Capecitabine—esophageal cancer	0.000105	0.00164	CcSEcCtD
Mitomycin—Body temperature increased—Methotrexate—esophageal cancer	0.000104	0.00162	CcSEcCtD
Mitomycin—Asthenia—Methotrexate—esophageal cancer	9.43e-05	0.00147	CcSEcCtD
Mitomycin—Diarrhoea—Methotrexate—esophageal cancer	8.99e-05	0.0014	CcSEcCtD
Mitomycin—Dizziness—Methotrexate—esophageal cancer	8.69e-05	0.00136	CcSEcCtD
Mitomycin—Vomiting—Methotrexate—esophageal cancer	8.35e-05	0.0013	CcSEcCtD
Mitomycin—Rash—Methotrexate—esophageal cancer	8.28e-05	0.00129	CcSEcCtD
Mitomycin—Dermatitis—Methotrexate—esophageal cancer	8.28e-05	0.00129	CcSEcCtD
Mitomycin—Headache—Methotrexate—esophageal cancer	8.23e-05	0.00129	CcSEcCtD
Mitomycin—Nausea—Methotrexate—esophageal cancer	7.8e-05	0.00122	CcSEcCtD
